Kiniksa Pharmaceuticals International plc (KNSA) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Kiniksa Pharmaceuticals International plc, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Kiniksa Pharmaceuticals International plc (KNSA) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $7.0B. It trades at $95.18, up 6.70% today. 5 analysts' average target of $98.60 implies +3.6% from today's price. Kronos AI's 30-day forecast is −24.1% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $98.60 |
| Low – high | $87.00 – $107.00 |
| Analysts | 5 |
| Upside to average | +3.6% |
Kronos AI 30-day forecast
| Expected close | $67.73 (−24.1%) |
| Likely range | −29.2% … −20.9% |
| As of | 2026-10-27 |
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator